Currently used for prostate cancer diagnosis, CZT-based sensors can also be used for imaging other cancers, such as cervical, colorectal, and breast cancers and can be optimized for use as a surgical probe that guides the removal of cancerous tumors.Hybridyne Imaging Technologies, based in Toronto, Canada, is a company that specializes in the development of compact gamma cameras for nuclear medici